MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Fibroblast Growth Factor Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

607 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
607 works in the cohort · of 4,299,418page 6 of 13

Labels cover 0 of 607 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 607 of 607 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
A phase I/II trial of escalating doses of recombinant human keratinocyte growth factor (rHuKGF) in head & neck cancer (HNC) patients receiving radiotherapy (RT) with concurrent chemotherapy (CCT)
David M. Brizel, Terence S. Herman, Don R. Goffinet, Scott L. Sailer, Sanjiv S. Agarwala, Gary N. Schwartz +5 more
2001· article· en· International Journal of Radiation Oncology*Biology*Physics· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
22
citations
affunlabeled
Role and expression of FRS2 and FRS3 in prostate cancer
Tania Valencia, Ajay Joseph, Naveen Kachroo, Susan O. Meakin, Vincent J. Gnanapragasam
2011· article· en· BMC Cancer· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
21
citations
afffundCorrection · OpenAlex missed itunlabeled
FGFR4 Polymorphic Variants Modulate Phenotypic Features of Cushing Disease
Tae Nakano-Tateno, Toru Tateno, Maw Maw Hlaing, Lei Zheng, Katsuhiko Yoshimoto, Shozo Yamada +2 more
2014· article· en· Molecular Endocrinology· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
21
citations
afffundno abstractunlabeled
Lrp6 is a target of the PTH-activated αNAC transcriptional coregulator
Martin Pellicelli, Julie Ann Miller, René St‐Arnaud
2018· article· en· Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
17
citations
← previousnext →

How this was built: Screen · Findings · About